Society Advocates to Medicare about Physician Payment and Telehealth

The Endocrine Society continues to advocate for physician payment and telehealth policies important to Society members.

In September, the Society submitted comments on the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2022. This annual rule updates payment policies and payment rates for Part B services furnished under the MPFS. In our letter, we provided comments on a wide range of policies proposed under the rule including the need for expanded access to telehealth services. We urged CMS to work towards making coverage of audio-only services permanent by releasing the utilization data that has been gathered on audio-only during the public health emergency (PHE). Releasing this data will help the Society work with CMS to address fraud and abuse concerns which have prevented expansion of audio-only telehealth.

In addition to telehealth, we also urged CMS to re-evaluate their proposed changes to practice expense (PE) values which will impact a wide range of services commonly billed by endocrinologists. The changes proposed under the rule could result in decreases to services such as traditional continuous glucose monitoring and fine needle aspiration. Society staff worked closely with the Clinical Affairs Core Committee (CACC) in drafting our comments. The proposed rule is expected to be finalized later this year and we will share an update with you when the final rule is published. In the meantime, if you’re interested in reading our comment letter, please visit the Society Letters page.

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…

Find more in